CMC Asset Lead, Nephrology: Strategy & Launch

Biogen, Inc.; Cambridge (MA); Hybrid; USD 204,000 - 281,000; Full time

Benefits offered by this job

Medical Insurance

Dental Insurance

Vision Insurance

Life Insurance

Fitness Reimbursement

Disability Insurance

Paid Vacation

Paid Holidays

Maternity/Parental Leave

401(k) with company match

Employee stock purchase plan

Tuition reimbursement

Employee Resource Groups

Job summary

Biogen, Inc. is seeking a CMC Asset Lead for the PO&T Nephrology team to oversee a critical asset across indications, including three Phase 3 studies, with commercialization targeted for 2028–2030.

You will drive asset strategy, launch planning, lifecycle management, and project financials in a highly matrixed environment. The role requires a strong strategic thinker with extensive biopharma experience, ability to influence without direct authority, and excellence in communication and

Qualifications

• BS or equivalent in Sciences/Engineering with an advanced degree (MS, PhD, MBA) preferred.
• Minimum of 12 years of experience with a focus on matrix management.
• Proven track record in matrix leadership across program teams and full product life cycle including commercial launch.
• Experience in alliance management, preferably global, and understanding of business contracts.
• Expertise in CMC, supply chain, or life cycle management development from IND to NDA/BLA.

Responsibilities

• Develop and maintain a 5-year PO&T Asset Strategy and an 18-month rolling Tactical Plan.
• Lead the cross-functional Asset Team to deliver on strategic objectives.
• Manage financial accountability, including AOP and FTE allocations, and monitor impacts on P&L.
• Develop business cases for key initiatives and secure management endorsement.
• Proactively resolve conflicts related to Asset Strategy with governance boards.
• Serve as the PO&T representative on commercial or development teams.

Skills

Matrix leadership

Cross-functional teamwork

Strategic thinking

Negotiation

Communication

Risk management

Stakeholder management

Decision making

Education

BS or equivalent in Sciences/Engineering

MS, PhD, or MBA in biopharma preferred

Job description

Biogen, Inc. is seeking a CMC Asset Lead for the PO&T Nephrology team to oversee a critical asset across indications, including three Phase 3 studies, with commercialization targeted for 2028–2030.

You will drive asset strategy, launch planning, lifecycle management, and project financials in a highly matrixed environment. The role requires a strong strategic thinker with extensive biopharma experience, ability to influence without direct authority, and excellence in communication and